Wells Fargo’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Wells Fargo's EW Position: Q2 2026 in Review
Wells Fargo reduced its Edwards Lifesciences (EW) stake by 3.7% in Q2 2026, selling an estimated $3.32M and leaving 1,041,675 shares worth $94.2M. The position accounts for 0.02% of the portfolio, ranked #707.
Wells Fargo first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $483M in Q2 2021. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Wells Fargo held 1,041,675 shares of Edwards Lifesciences worth $94.2M as of Q2 2026.
- Wells Fargo sold 39,596 Edwards Lifesciences shares in Q2 2026, an estimated $3.32M.
- Edwards Lifesciences made up 0.02% of Wells Fargo's portfolio in Q2 2026, its #707 holding.
- Wells Fargo first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Edwards Lifesciences position peaked at $483M in Q2 2021.
- 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.